Skip to main content

Animations

MJFF Publications

2631 - 2640 of 6255 Results
Title
Year
  • Year
  • 2017
  • 2018
  • 2017
  • 2021
  • 2023
  • 2022
  • 2023
  • 2018
  • 2015
  • 2024
  • Summary Details
    OPEN
    Title: Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.12.006
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.006
    Citation Count: 69
  • Summary Details
    OPEN
    Title: Distinct alterations in Parkinson's medication-state and disease-state connectivity
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.09.004
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Bach1 derepression is neuroprotective in a mouse model of Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2111643118
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Clinical severity in Parkinson’s disease is determined by decline in cortical compensation
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awad325
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00322-x
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26738
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Increased substantia nigra echogenicity in LRRK2 family members without mutations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27443
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer’s disease patients
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2015.02.013
    Citation Count: 11
  • Summary Details
    OPEN
    Title: In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae404
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.